Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Early results from Alzheimer's neuroimaging studies could speed research
June 26th, 2007
Alzheimer’s disease researchers may be able to reduce the time and expense associated with clinical trials, according to early results from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a public-private research partnership organized by the National Institutes of Health. Preliminary results from ADNI show how it might yield improved methods and uniform standards for imaging and biomarker analysis, so these techniques can be employed in the fight against Alzheimer’s disease. These first findings will be presented at the Alzheimer’s Association International Conference on the Prevention of Dementia being held in Washington, D.C., June 9-12. ...
Source: Drug Law Weekly (2007-06-26)
|
